These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25996579)

  • 21. The one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.
    Yao J; Shan H; Chen Y; Jiang ZG; Dai XW; Ren JJ; Xu KJ; Ruan B; Yang SG; Li Q
    Hum Vaccin Immunother; 2015; 11(5):1114-9. PubMed ID: 25692413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
    Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Wu Q; Zhuang GH; Wang XL; Wang LR; Li N; Zhang M
    Vaccine; 2011 Mar; 29(12):2302-7. PubMed ID: 21277403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Persistence of immune memory to hepatitis B vaccine among infants with normal or high antibody response to primary vaccination: a five-year following-up study].
    Zhang L; Yan B; Liu J; Lyu J; Feng Y; Xu A; Song L; Liang X; Li L; Cui F; Zhang G; Wang F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1372-6. PubMed ID: 26850392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
    Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
    Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B
    Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
    Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
    Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
    Yao J; Ren J; Shen L; Chen Y; Liang X; Cui F; Li Q; Jiang Z; Wang F
    Hum Vaccin; 2011 Oct; 7(10):1055-9. PubMed ID: 21989290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the status of immune memory after completion of hepatitis B vaccination].
    Li YP; Li RC; Fang KX; Li HM; Hu ZY; He P; Wu XY; Zhang R; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):319-21. PubMed ID: 17850693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of plasma-derived hepatitis B vaccine 23(rd) year after a full course of vaccination in healthy young children].
    Wu Q; Wang XL; Deng YL; Wang LR; Gao HY; Zhuang GH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Oct; 45(10):920-3. PubMed ID: 22321594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in China.
    Wu W; Lv J; Liu J; Yan B; Feng Y; Xu A; Zhang L
    Hum Vaccin Immunother; 2018; 14(10):2485-2490. PubMed ID: 29993330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: A 5-year follow-up study.
    Wu Z; Yao J; Bao H; Chen Y; Lu S; Li J; Yang L; Jiang Z; Ren J; Xu KJ; Ruan B; Yang SG; Xie TS; Li Q
    Hum Vaccin Immunother; 2018 May; 14(5):1251-1256. PubMed ID: 29337651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children.
    Hanna JN; Faoagali JL; Buda PJ; Sheridan JW
    J Paediatr Child Health; 1997 Feb; 33(1):67-70. PubMed ID: 9069048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
    Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
    Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
    BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.